Heart failure patients get personalized fitness coaching to keep rehab benefits
NCT ID NCT06222762
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether personalized support from a sport and health professional after cardiac rehabilitation helps heart failure patients maintain their physical activity levels. 90 participants will be followed for 12 months, with activity measured by a step counter. The goal is to see if tailored coaching can prevent the loss of benefits that often happens when patients return home.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- personalized follow-up in adapted physical activities
- What this could lead to
- If successful, this approach could help heart failure patients maintain the benefits of cardiac rehabilitation for a longer period, improving their quality of life and reducing hospitalizations.
- What could go wrong
- This is a small, early-stage study (90 participants) testing a behavioral intervention, not a drug. Results may not apply to all heart failure patients, and long-term adherence to physical activity remains challenging.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 90 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2024
- Expected to finish
-
Sep 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosis of stable heart failure with NYHA stage I, II or III * Participation in a cardiac rehabilitation programme * Patient agreement * Patient of legal age * Patient affiliated to the Social Security Exclusion Criteria: * Patient refusal * Minor patients * Subjects under guardianship or curatorship * Subjects over 80 years of age at the time of inclusion
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Heart failure are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
CHU de Brest
RECRUITINGBrest, 29609, France
-
Fondation ILDYS
RECRUITINGBrest, 29200, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- Can daily mindful breathing ease heart failure symptoms?
- Can a smartphone app keep heart failure patients out of the hospital?
- Can better training get doctors to talk about what matters most to dying veterans?
- Can AI read heart ultrasounds as well as trained sonographers?
- Can modern heart failure drugs reverse damage in three months?